These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
739 related items for PubMed ID: 17139372
21. Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes. Li Y, Spencer FA, Ball S, Becker RC. J Thromb Thrombolysis; 2000 Aug; 10(1):69-76. PubMed ID: 10947916 [Abstract] [Full Text] [Related]
22. Pharmacological characteristics of solid-phase von Willebrand factor in human platelets. Radomski A, Stewart MW, Jurasz P, Radomski MW. Br J Pharmacol; 2001 Nov; 134(5):1013-20. PubMed ID: 11682449 [Abstract] [Full Text] [Related]
23. Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity. Goto S, Tamura N, Li M, Handa M, Ikeda Y, Handa S, Ruggeri ZM. J Thromb Haemost; 2003 Sep; 1(9):2022-30. PubMed ID: 12941046 [Abstract] [Full Text] [Related]
25. Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX-von willebrand factor interaction. Mistry N, Cranmer SL, Yuan Y, Mangin P, Dopheide SM, Harper I, Giuliano S, Dunstan DE, Lanza F, Salem HH, Jackson SP. Blood; 2000 Nov 15; 96(10):3480-9. PubMed ID: 11071645 [Abstract] [Full Text] [Related]
26. Inhibition of shear-stress-induced platelet aggregation and phosphotyrosine signaling by GPIIb-IIIa antagonists. Haga JH, Jennings LK, Slack SM. Ann Biomed Eng; 2002 Nov 15; 30(10):1262-72. PubMed ID: 12540202 [Abstract] [Full Text] [Related]
27. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. Danton MC, Zaleski A, Nichols WL, Olson JD. J Lab Clin Med; 1994 Aug 15; 124(2):274-82. PubMed ID: 8051492 [Abstract] [Full Text] [Related]
28. Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond. Giordano A, Musumeci G, D'Angelillo A, Rossini R, Zoccai GB, Messina S, Coscioni E, Romano S, Romano MF. Curr Drug Metab; 2016 Aug 15; 17(2):194-203. PubMed ID: 26652157 [Abstract] [Full Text] [Related]
29. Inhibition and reversal of platelet aggregation by alphaIIbbeta3 antagonists depends on the anticoagulant and flow conditions: differential effects of Abciximab and Lamifiban. Frojmovic M, Labarthe B, Legrand C. Br J Haematol; 2005 Nov 15; 131(3):348-55. PubMed ID: 16225655 [Abstract] [Full Text] [Related]
30. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses. Matsumoto Y, Marukawa K, Okumura H, Adachi T, Tani T, Kimura Y. Thromb Res; 1999 Jul 01; 95(1):19-29. PubMed ID: 10403683 [Abstract] [Full Text] [Related]
31. Abciximab pharmacodynamics are unaffected by antecedent therapy with other GPIIb/IIIa antagonists in non-human primates. Nakada MT, Sassoli PM, Tam SH, Nedelman MA, Jordan RE, Kereiakes DJ. J Thromb Thrombolysis; 2002 Aug 01; 14(1):15-24. PubMed ID: 12652146 [Abstract] [Full Text] [Related]
33. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Wu YP, Vink T, Schiphorst M, van Zanten GH, IJsseldijk MJ, de Groot PG, Sixma JJ. Arterioscler Thromb Vasc Biol; 2000 Jun 01; 20(6):1661-7. PubMed ID: 10845886 [Abstract] [Full Text] [Related]
34. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction. Cauwenberghs N, Ajzenberg N, Vauterin S, Hoylaerts MF, Declerck PJ, Baruch D, Deckmyn H. Haemostasis; 2000 Jun 01; 30(3):139-48. PubMed ID: 11014964 [Abstract] [Full Text] [Related]
35. Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists. Ilveskero S, Lassila R. Thromb Res; 2006 Jun 01; 117(3):291-7. PubMed ID: 15878612 [Abstract] [Full Text] [Related]
36. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor. Cauwenberghs N, Schlammadinger A, Vauterin S, Cooper S, Descheemaeker G, Tornai I, Deckmyn H. Thromb Haemost; 2001 Apr 01; 85(4):679-85. PubMed ID: 11341505 [Abstract] [Full Text] [Related]
37. Comparative studies of a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, and abciximab on in vitro antiplatelet effect and binding properties. Suzuki K, Sato K, Kamohara M, Kaku S, Kawasaki T, Yano S, Iizumi Y. Biol Pharm Bull; 2002 Aug 01; 25(8):1006-12. PubMed ID: 12186399 [Abstract] [Full Text] [Related]
38. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Mazurov AV, Vinogradov DV, Vlasik TN, Repin VS, Booth WJ, Berndt MC. Thromb Res; 1991 Jun 15; 62(6):673-84. PubMed ID: 1718052 [Abstract] [Full Text] [Related]
39. Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow? Jung SM, Sonoda M, Tsuji K, Jimi A, Nomura S, Kanaji T, Moroi M. Platelets; 2010 Jun 15; 21(2):101-11. PubMed ID: 20063990 [Abstract] [Full Text] [Related]
40. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis. Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J. Thromb Haemost; 1998 Jun 15; 79(6):1184-90. PubMed ID: 9657446 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]